Login / Signup
Emma Tyas
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 4
Top Topics
Combination Therapy
Smoking Cessation
Palliative Care
Top Venues
PharmacoEconomics - open
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Colin Burke
,
Catriona Crossan
,
Emma Tyas
,
Matthew Hemstock
,
Dawn Lee
,
Sally Bowditch
A Cost-Utility Analysis of Add-On Cannabidiol Versus Usual Care Alone for the Treatment of Seizures Associated with Tuberous Sclerosis Complex in England and Wales.
PharmacoEconomics - open
(2024)
Colin Burke
,
Catriona Crossan
,
Emma Tyas
,
Matthew Hemstock
,
Dawn Lee
,
Sally Bowditch
A Cost-Utility Analysis of Add-On Cannabidiol Versus Usual Care Alone for the Treatment of Seizures Associated with Tuberous Sclerosis Complex in England and Wales.
PharmacoEconomics - open
8 (4) (2024)
Colin Burke
,
Catriona Crossan
,
Emma Tyas
,
Matthew Hemstock
,
Dawn Lee
,
Sally Bowditch
A Cost-Utility Analysis of Add-On Cannabidiol Versus Usual Care Alone for the Treatment of Seizures Associated with Tuberous Sclerosis Complex in England and Wales.
PharmacoEconomics - open
8 (4) (2024)
Colin Burke
,
Catriona Crossan
,
Emma Tyas
,
Matthew Hemstock
,
Dawn Lee
,
Sally Bowditch
A Cost-Utility Analysis of Add-On Cannabidiol Versus Usual Care Alone for the Treatment of Seizures Associated with Tuberous Sclerosis Complex in England and Wales.
PharmacoEconomics - open
8 (4) (2024)